Targeting prostate cancer with Clostridium perfringens enterotoxin functionalized nanoparticles co-encapsulating imaging cargo enhances magnetic resonance imaging specificity
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 40, 102477
Abstract
No abstract availableKeywords
Funding Information
- Department of Defense Prostate Cancer Research Program
This publication has 34 references indexed in Scilit:
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical ProstatectomyPLOS ONE, 2013
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological ProfileScience Translational Medicine, 2012
- Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugatesJournal of Controlled Release, 2011
- Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: Comparison with stealth liposomesJournal of Controlled Release, 2011
- Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinomaDiagnostic Pathology, 2011
- Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancerBritish Journal of Cancer, 2008
- Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targetingBiomaterials, 2005
- An overview of Clostridium perfringens enterotoxinToxicon, 1996
- Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1994
- THE ROLE OF OPSONINS IN THE CLEARANCE OF LIVING AND INERT PARTICLES BY CELLS OF THE RETICULOENDOTHELIAL SYSTEMJournal of Experimental Medicine, 1961